Site icon pharmaceutical daily

Global Respiratory Diseases Drugs Market Forecast to 2022: Anti-Asthmatics & COPD Drugs, Cough & Cold Preparations – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Respiratory Diseases Drugs Global Market Forecast To 2022” report has been added to ResearchAndMarkets.com’s offering.

Where is the largest and fastest growing market for the respiratory diseases drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The report answers all these questions and many more.

North America was the largest region in the global respiratory diseases drugs market, accounting for 42% of the market in 2018. Western Europe was the second largest region accounting for 27% of the global respiratory diseases drugs market. Africa was the smallest region in the global respiratory diseases drugs market.

The demand for PSE-containing cold, allergy, and sinus products is growing due to their effectiveness and convenience. PSE is an active ingredient found in various cold, allergy, and sinus drugs that can provide congestion relief. However, PSE-containing medicines are mostly sold as a prescription drug, as PSE can also be used for the illegal manufacture of methamphetamine, a recreational drug. This has led drug manufacturers to produce tamper-resistant PSE products.

For instance, in March 2017, pharmaceutical companies Acura Pharmaceuticals Inc. and MainPointe Pharmaceuticals LLC entered into an agreement, enabling MainPointe Pharmaceuticals LLC to market NEXAFED and NEXAFED Sinus products in the US and Canada. These drugs utilize tamper-resistant PSE formulation to prevent the illicit production of methamphetamine.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

Scope

Key Topics Covered

1. Executive Summary

2. Report Structure

3. Respiratory Diseases Drugs Market Characteristics

3.1. Market Definition

3.2. Key Segmentations

4. Respiratory Diseases Drugs Market Product Analysis

4.1. Leading Products/Services

4.2. Key Features and Differentiators

4.3. Development Products

5. Respiratory Diseases Drugs Market Supply Chain

5.1. Supply Chain

5.2. Distribution

5.3. End Customers

6. Respiratory Diseases Drugs Market Customer Information

6.1. Customer Preferences

6.2. End Use Market Size and Growth

7. Respiratory Diseases Drugs Market Trends & Strategies

8. Respiratory Diseases Drugs Market Size & Growth

8.1. Market Size

8.2. Historic Market Growth, Value ($ Billion)

8.2.1. Drivers Of The Market

8.2.2. Restraints On The Market

8.3. Forecast Market Growth, Value ($ Billion)

8.3.1. Drivers Of The Market

8.3.2. Restraints On The Market

9. Respiratory Diseases Drugs Market Regional Analysis

9.1. Global Respiratory Diseases Drugs Market, 2018, By Region, Value ($ Billion)

9.2. Global Respiratory Diseases Drugs Market, 2014 – 2022, Historic And Forecast, By Region

9.3. Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region

10. Respiratory Diseases Drugs Market Segmentation

10.1. Global Respiratory Diseases Drugs Market, Segmentation By Type, 2014 – 2022, Value ($ Billion)

10.1.1. Anti-Asthmatics And COPD Drugs

10.1.2. Cough And Cold Preparations

11. Respiratory Diseases Drugs Market Metrics

11.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, 2014 – 2022, Global

11.2. Per Capita Average Respiratory Diseases Drugs Market Expenditure, 2014 – 2022, Global

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/bipvt7

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version